MyFinsight
Home
Compare
Blog
About
Cash and cash
equivalents
$35,586K
Short-term investments
$7,423K
Receivable from
collaboration partners
$1,107K
Prepaid expenses and
other current assets
$989K
Total
$17,946K
Total current assets
$45,105K
Property and equipment,
net
$5,755K
Other long-term
assets
$3,610K
Operating lease
right-of-use asset
$2,782K
Restricted cash
$675K
Less accumulated
depreciation and...
$12,191K
Total assets
$57,927K
Accumulated deficit
-$181,531K
Accumulated other
comprehensive income
-$2K
Total liabilities,
preferred stock, and...
$57,927K
Total stockholders'
deficit
-$164,846K
Additional paid-in capital
$16,673K
Common stock, 0.001 par
value, 52,000,000...
$14K
Redeemable convertible
preferred stock, 0.001 par...
$120,356K
Total liabilities
$102,417K
Total current
liabilities
$78,697K
Deferred revenue,
non-current
$11,698K
Other non-current
liabilities
$7,920K
Operating lease
liabilities, net of current...
$4,102K
Convertible note
$37,799K
Deferred revenue,
current
$27,475K
Accrued expenses and
other current...
$7,183K
Accounts payable
$2,771K
Accrued license fees
$2,100K
Operating lease
liabilities, current portion
$1,369K
Back
Back
Balance Sheet
Scribe Therapeutics, Inc. (SCTX)
Scribe Therapeutics, Inc. (SCTX)
source: myfinsight.com